ReviewJournal of clinical pathology2007
Demystifying basal-like breast carcinomas.
Review in Journal of clinical pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Subtype-specific alternative splicing events in breast cancer identified by large-scale data analysis.Scientific reports · 2024Article
- Prognostic Value of "Basal-like" Morphology, Tumor-Infiltrating Lymphocytes and Multi-MAGE-A Expression in Triple-Negative Breast Cancer.International journal of molecular sciences · 2024Article
- Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer.Frontiers in oncology · 2020Article
- Morphological and pathological features of basal-like breast cancer.Translational cancer research · 2019Review
- Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.Scientific reports · 2015Article
- Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.PloS one · 2015Article
- Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations.British journal of cancer · 2014Article
- [Determination of proliferation in breast cancer by immunohistochemical detection of Ki-67].Der Pathologe · 2014Article
- Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells.Cancer biology & therapy · 2013Article
- [Translational research and diagnostics for breast cancer].Der Pathologe · 2012Review
- Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China.Cancer science · 2012Article
- Molecular aspects of breast cancer metastasis to the brain.Genetics research international · 2011Article
- EGFR signaling in breast cancer: bad to the bone.Seminars in cell & developmental biology · 2010Review
- p16INK4a expression in basal-like breast carcinoma.International journal of clinical and experimental pathology · 2010Article
- [Beyond staging, typing and grading. New challenges in breast cancer pathology].Der Pathologe · 2010Review
- Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.Breast cancer research : BCR · 2010Article
- Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2009Article
- PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.The Journal of biological chemistry · 2009Article
- Expression of tight junction protein claudin-4 in basal-like breast carcinomas.Pathology oncology research : POR · 2009Article
- Igf1r as a therapeutic target in a mouse model of basal-like breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
"Basal" breast cancers are dominating the breast research literature at present and pathologists are under increasing pressure to evaluate for such a phenotype by their surgical and oncological colleagues. There is also much confusion about how to assess cancers, which immunohistochemical markers to use, what meaning and benefit this provides, and what the surgeons and oncologists will do with the information. Much remains to be done to answer all these questions but here we try to shed light on some of the issues and suggest what is still to come.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.